Agios Pharmaceuticals’ Post

📢 New podcast episode alert! In Episode 27 of "Just Listen, Voices of PK Deficiency," host Dr. Rachael Grace sits down with Tamara Schryver, Thrive with PKD and Alejandra Watson, PKD Foundation to discuss the newly available international PKD guidelines. Learn how these guidelines are revolutionizing care for patients and what it means for the community. 🎧👩⚕️ Check it out here: https://lnkd.in/gc7CURAs #PKDGuidelines #PatientCare Listen, rate, review, and subscribe wherever you get your podcasts! Or by clicking here: www.JustListenPod.com Just Listen: Voices of PK deficiency is a podcast about pyruvate kinase (PK) deficiency and is intended for patients, caregivers, providers, and the greater community of people who are impacted by PK deficiency. Each episode of the Just Listen: Voices of PK deficiency podcast strives to provide listeners with critical education, the latest scientific updates, and voices from the PK deficiency community. Just Listen: Voices of PK deficiency is sponsored by Agios Pharmaceuticals Inc. Visit Agios.com to learn more. Learn more about PK deficiency by visiting KnowPKDeficiency.com or connect with KnowPKDeficiency on Facebook: bit.ly/KnowPKD. For more information on the International Guidelines for the Diagnosis & Management of Pyruvate Kinase Deficiency: https://pkdguidelines.org/ This podcast is not intended as medical advice. Please consult your healthcare team with any treatment re­lated questions. #RedBloodCellDisorder #HereditaryDisease

The new AMDA On-The-Go #podcast is a special Drive to Deprescribe edition, Deprescribing of Anticoagulants: The If, When, and How, A Discussion with a Cardiologist. It delves into updated guidelines and the intricacies of deprescribing anticoagulants: https://bit.ly/4bU8Ho3

A quick (10 min), solid overview of the very interesting TXNIP/TXNIP inhibition --> Verapamil --> and now, TIX100, story with Dr. Anath Shalev

Identifying the value of your product is key to market access and commercialisation for Medtech and Diagnostics. Here, my colleague, Samantha Gillard (Director – HTA, Mtech Access), outlines 4 key elements for your Medtech value and evidence strategy: 1) Unmet need – what is the unmet need in your disease area? 2) Treatment positioning – how is your treatment positioned in that disease area? Where does your treatment fit in the care pathway? 3) Comparative clinical value – what comparative clinical value does your product bring? How is your product better than what is currently being used? 4) Economic value – what is the economic value to healthcare providers? Can you demonstrate this? Addressing these questions effectively will help you showcase your product's value. A well-supported value proposition that addresses these points is crucial for engaging with healthcare decision-makers. While it may seem straightforward, payers and healthcare decision-makers will demand solid evidence that supports your claims of value. If you need assistance with building a strong evidence base or want to discuss strategies for evidence synthesis and commercialisation, reach out to us at [email protected] This clip (full recording now available on demand) was taken from our recent webinar exploring evidence strategy for medical technologies and diagnostics: https://lnkd.in/etdjqG54. You can also find the episode on our podcast. Search for 'Pharma Market Access Insights – from Mtech Access’ on Spotify, Apple Podcasts, or Google Podcasts. #Medtech #MedicalDevices #Diagnostics #evidence #evidencestrategy #clinicalvalue #economicvalue #healtheconomics #HTA

Identifying the value of your product is key to market access and commercialisation for Medtech and Diagnostics. Here, my colleague, Samantha Gillard (Director – HTA, Mtech Access), outlines 4 key elements for your Medtech value and evidence strategy: 1) Unmet need – what is the unmet need in your disease area? 2) Treatment positioning – how is your treatment positioned in that disease area? Where does your treatment fit in the care pathway? 3) Comparative clinical value – what comparative clinical value does your product bring? How is your product better than what is currently being used? 4) Economic value – what is the economic value to healthcare providers? Can you demonstrate this? Addressing these questions effectively will help you showcase your product's value. A well-supported value proposition that addresses these points is crucial for engaging with healthcare decision-makers. While it may seem straightforward, payers and healthcare decision-makers will demand solid evidence that supports your claims of value. If you need assistance with building a strong evidence base or want to discuss strategies for evidence synthesis and commercialisation, reach out to us at [email protected] This clip (full recording now available on demand) was taken from our recent webinar exploring evidence strategy for medical technologies and diagnostics: https://lnkd.in/eX7DP428. You can also find the episode on our podcast. Search for 'Pharma Market Access Insights – from Mtech Access’ on Spotify, Apple Podcasts, or Google Podcasts. #Medtech #MedicalDevices #Diagnostics #evidence #evidencestrategy #clinicalvalue #economicvalue #healtheconomics #HTA

NEW PODCAST EPISODE! In this episode of The FAST Archives, William Heuser brings his extensive experience as a clinical critical care pharmacist, clinical toxicologist, and certified Flight Paramedic to demystify the controversial world of resuscitative medicine. In his dynamic talk, "Do Any of These Medications Work in Cardiac Arrest? Demystifying the Controversies!", Will examines the debate surrounding the administration of certain medications during cardiac arrest. He discusses how these medications impact patient outcomes during resuscitation and offers a clear, evidence-based analysis of their risks and benefits. William’s unique blend of humor, energy, and knowledge makes this talk as entertaining as it is informative. Tune in to gain valuable insights into the evolving field of resuscitative medicine and explore the complexities of pharmacological interventions during cardiac arrest. If you're interested in joining us at FAST24 for more talks like this, visit https://lnkd.in/gapSbEwd. You can listen to this episode and more on your favorite podcast app, or listen on our website at: https://lnkd.in/g5xVmKUm. Thanks for listening, and we hope you enjoy this episode!

Thank you, Dr. Toyosi Onwuemene, fellow hematologist and amazing researcher to invite me as a guest on your podcast. Many physicians who are academic researchers also have clinical responsbilities to see patients in between their research time. Here I share my journey from charting into the late nights to going home with all my clinical work done by 5 pm, seeing the same number of patients, and how I use my experience to transform other physicians to do the same. I invite you to listen to this episode. Link in comments. #efficiency #efficiencymatters #charting #patientcare #leaveworkatwork #transformation #lifecoaching #lifecoachinghappiness #physiciancoaching #enjoylife #enjoymedicine

Identifying the value of your product is key to market access and commercialisation for Medtech and Diagnostics. Here, my colleague, Samantha Gillard (Director – HTA, Mtech Access), outlines 4 key elements for your Medtech value and evidence strategy: 1) Unmet need – what is the unmet need in your disease area? 2) Treatment positioning – how is your treatment positioned in that disease area? Where does your treatment fit in the care pathway? 3) Comparative clinical value – what comparative clinical value does your product bring? How is your product better than what is currently being used? 4) Economic value – what is the economic value to healthcare providers? Can you demonstrate this? Addressing these questions effectively will help you showcase your product's value. A well-supported value proposition that addresses these points is crucial for engaging with healthcare decision-makers. While it may seem straightforward, payers and healthcare decision-makers will demand solid evidence that supports your claims of value. If you need assistance with building a strong evidence base or want to discuss strategies for evidence synthesis and commercialisation, reach out to us at [email protected] This clip (full recording now available on demand) was taken from our recent webinar exploring evidence strategy for medical technologies and diagnostics: https://lnkd.in/eQ4mvZN8. You can also find the episode on our podcast. Search for 'Pharma Market Access Insights – from Mtech Access’ on Spotify, Apple Podcasts, or Google Podcasts. #Medtech #MedicalDevices #Diagnostics #evidence #evidencestrategy #clinicalvalue #economicvalue #healtheconomics #HTA

Is the road to clinical trial participation unnecessarily complicated? In our latest podcast, Megan Liles addresses this critical issue. 🙏 A big thank you to Megan for joining us on the podcast and: - Sharing her insights on making clinical trials more accessible and patient-centric - Highlighting the challenges patients face when navigating the clinical trial space 🔎 One thing we talked about is how patients look for trials: - Platforms like clinicaltrials.gov are often too complex for people to navigate - This complexity ends up unintentionally deterring patient participation 💡Takeaway: Despite calls for patient centricity, it's almost like we don't want patients to participate because we put all these barriers in place. Megan's perspective highlights the need for improving access to trials, and making it easier for patients. Check out the full episode. Link in the comments! 👇 #clinicaltrials #clinicalresearch #patientcentricity

Identifying the value of your product is key to market access and commercialisation for Medtech and Diagnostics. Here, my colleague, Samantha Gillard (Director – HTA, Mtech Access), outlines 4 key elements for your Medtech value and evidence strategy: 1) Unmet need – what is the unmet need in your disease area? 2) Treatment positioning – how is your treatment positioned in that disease area? Where does your treatment fit in the care pathway? 3) Comparative clinical value – what comparative clinical value does your product bring? How is your product better than what is currently being used? 4) Economic value – what is the economic value to healthcare providers? Can you demonstrate this? Addressing these questions effectively will help you showcase your product's value. A well-supported value proposition that addresses these points is crucial for engaging with healthcare decision-makers. While it may seem straightforward, payers and healthcare decision-makers will demand solid evidence that supports your claims of value. If you need assistance with building a strong evidence base or want to discuss strategies for evidence synthesis and commercialisation, reach out to us at [email protected] This clip (full recording now available on demand) was taken from our recent webinar exploring evidence strategy for medical technologies and diagnostics: https://lnkd.in/euWk9B9F. You can also find the episode on our podcast. Search for 'Pharma Market Access Insights – from Mtech Access’ on Spotify, Apple Podcasts, or Google Podcasts. #Medtech #MedicalDevices #Diagnostics #evidence #evidencestrategy #clinicalvalue #economicvalue #healtheconomics #HTA